DGNMF (Diagnamed Holdings) Total Tax Payable : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Diagnamed Holdings Total Tax Payable?

Diagnamed Holdings's Total Tax Payable for the quarter that ended in Dec. 2024 was $0.00 Mil.

Diagnamed Holdings Total Tax Payable Historical Data

The historical data trend for Diagnamed Holdings's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings Total Tax Payable Chart

Diagnamed Holdings Annual Data

Trend

Sep21

Sep22

Sep23

Sep24

Total Tax Payable

Diagnamed Holdings Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Tax Payable	Get a 7-Day Free Trial									-	-	-	-	-

Diagnamed Holdings Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Diagnamed Holdings Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnamed Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (OTCPK:DGNMF) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

DMED:Canada

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.diagnamed.com

Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.